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NK3 homeobox 1 (Nkx3.1), a transcription factor expressed in
theprostate epithelium, is crucial formaintainingprostate cell fate
andsuppressing tumor initiation.Nkx3.1 isubiquitouslyexpressed
in luminal cells of hormonally intact prostate but, upon androgen
deprivation, exclusively labels a type of luminal stem cells named
castration-resistant Nkx3.1-expressing cells (CARNs). During
prostate cancer initiation, Nkx3.1 expression is frequently lost in
both humans and mouse models. Therefore, investigating how
Nkx3.1expression is regulated in vivo is important forunderstand-
ing the mechanisms of prostate stem cell specification and cancer
initiation. Here, using a transgenic mouse line with destabilized
GFP, we identified an 11-kb genomic region 3 of theNkx3.1 tran-
scription start site to be responsible for alterations in Nkx3.1
expression patterns under various physiological conditions. We
found that androgen cell-autonomously activates Nkx3.1 expres-
sion through androgen receptor (AR) binding to the 11-kb region
in both normal luminal cells and CARNs and discovered new
androgen response elements in theNkx3.1 3UTR. In contrast, we
foundthat, inPten/prostate tumors, lossofNkx3.1expression is
mediated at the transcriptional level through the 11-kb region
despite functional AR in the nucleus. Importantly, the GFP
reporter specifically labeled CARNs in the regressed prostate only
in the presence of cell-autonomous AR, supporting a facultative
model for CARN specification.
The homeodomain-containing protein Nkx3.1 is the earliest
known transcription factor expressed in prostate development (1,
2) and orchestrates a transcriptional regulatory network impor-
tant for prostate cell fate specification (3). The mature prostate
gland contains stromal layers and an epithelium that is composed
of secretory luminal cells, basal cells, and rare neuroendocrine
cells.Nkx3.1 is primarily expressed in luminal epithelial cells of the
adult prostate, with low levels present in a small subset of basal
cells (4, 5). It plays a tumor-suppressing role, as both homozygous
andheterozygousNkx3.1mutantmice display increases in epithe-
lial hyperplasia and defects in prostate branching and protein
secretionas they age (6–9). Inhumans,Nkx3.1down-regulation is
considered one of the earliest events in prostate cancer initiation
(10).Mechanistically,Nkx3.1 has been shown toplay a critical role
in protecting prostate cells fromDNA damage (11–14).
Despite its functional significance, how Nkx3.1 expression is
regulated in normal and tumorigenic prostate in vivo remains
elusive. Nkx3.1 mRNA is detected in prostatic buds in E17.5
mouse embryos (2), and studies using urogenital sinus explant
culture have demonstrated the involvement of the Fgf10 and
Wnt signaling pathways in activatingNkx3.1 expression during
prostate organogenesis (15–18). In postnatal and adult pros-
tate, androgen receptor (AR)3 signaling has been shown to
maintain Nkx3.1 expression. In particular, androgen depriva-
tion via castration in mice induced prostate regression accom-
panied by apoptosis in the majority of luminal cells and loss of
Nkx3.1 expression in the ones that survived (1, 2, 5), although
the relative contribution of cell-autonomous luminal AR versus
non-cell-autonomous stromal AR in this process has yet to be
determined. Notably, a small subset of the surviving luminal
cells retained Nkx3.1 expression in the regressed prostate.
Those cells, named castration-resistant Nkx3.1-expressing
cells (CARNs), were shown to behave as luminal stem cells that
contribute to prostate regeneration upon androgen readminis-
tration and could also serve as a cell of origin for prostate cancer
(5). How CARNs are specified is unclear; the retention of their
Nkx3.1 expression could be due to an intrinsically different
cellular program from other luminal cells or, alternatively,
stochastically determined by the local microenvironment.
Another important question concerning Nkx3.1 expression
arises from studies of prostate cancer. Under prostate tumor–
initiating conditions, such as the loss of Pten, luminal Nkx3.1
expression is abolished in both human samples and mouse
models (19–22). How this is accomplished remains unclear.
The decrease ofNkx3.1mRNA in Pten/ tumors suggests that
the regulation may occur at the transcriptional level (20, 23),
whereas the loss of Nkx3.1 protein, but not mRNA, in Pten/
tumors suggests the existence of translational or posttransla-
tional regulation (19).
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We reason that studying Nkx3.1 transcriptional regulation by
analysis of the Nkx3.1 gene locus should shed light on the above
questions. A pioneer study using transgenic LacZ reporter mice
discovered that a 32-kb fragment containing 20 kb upstream and
12 kb downstream of the Nkx3.1 transcription start site (TSS)
could drive the endogenous Nkx3.1 expression pattern in most
organsduringembryogenesis (4).Within this fragment, thedown-
stream-most 5-kb region acted as a urogenital enhancer that par-
tially restored prostatic Nkx3.1 expression (4). Based on this find-
ing, we hypothesize that change of Nkx3.1 expression in adult
prostate in vivo is regulated transcriptionally through its 3 local
genomic region.Ourdata belowsupport this hypothesis by testing
it in the contexts of both prostate regression–regeneration and
Pten loss–induced cancer initiation. They also support a faculta-
tive model for CARN specification.
Results
An 11-kb Nkx3.1 region drives normal gene expression
in adult prostate
To test the hypothesis that change of prostatic Nkx3.1
expression ismediated transcriptionally through its 3 genomic
sequence in vivo, we took a transgenic reporter mouse
approach by constructing an 11-kb DNA fragment contain-
ing the 240-bp Nkx3.1 proximal promoter, the 4-kb Nkx3.1
gene sequence, and its adjacent 3 6.5-kb intergenic region (Fig.
1A). In addition, for visualizing loss of Nkx3.1 expression under
androgen deprivation and tumor initiation conditions, we
inserted the d2EGFP sequence encoding a destabilized GFP (24)
withanSV40poly(A)sequencerightafter thestart codon(Fig.1A).
With a half-life of 2 h, the d2EGFP should dynamically report the
Nkx3.1 transcriptional activities in vivo. The final construct
(named Nkx3.1(11)-d2EGFP) was used for pronuclear injection,
and five independent transgenic mouse lines were obtained. A
robust GFP signal was observed specifically in the adult prostate;
four of the five lines showed strong tomoderateGFPexpression in
various prostate lobes, whereas one line showed weak expression
(Fig. 1B and supplemental Fig. S1 and Table S1). For subsequent
analyses, we focused on transgenic line 18 (Ntg18) because it dis-
played the strongest expression inall lobesof theprostate (Fig. 1B).
We next examined reporter gene expression during embryo-
genesis and prostate development. No GFP was observed in
somites of E10.5 embryos in any of the lines, consistent with a
previous report showing that key elements for somite Nkx3.1
expression lie in the 5 region of the gene locus (4). We also did
not detect GFP in E18.5 prostate buds, where cells mostly
expressed the basal marker CK5 (Fig. 1C). GFP began to be
expressed in the prostate around neonatal stage P4. By neonatal
stage P8, GFP was expressed throughout the prostate epithe-
lium, which contained basal (CK5), luminal (CK18) and
intermediate cells (CK5CK18) and co-localized with Nkx3.1
expression (Fig. 1D and supplemental Fig. S2A). Throughout
the adult stage, GFP expression was persistently present in the
luminal layer and co-localized with Nkx3.1 expression (Fig. 1, E
and F). The proportions of luminal cells that were GFP in the
anterior, ventral, and dorsal-lateral prostate lobes (AP, VP, and
DLP, respectively) were 98.2% (n 2019 of 2055), 67.2% (n 839
of 1248), and 87.1% (n 1283 of 1473), respectively (Fig. 1G and
supplemental Fig. S2, B–D). Notably, 5.8% (n  95 of 1638) of
basal cellswere alsoGFP (Fig. 1,G andH), in agreementwith the
percentage ofNkx3.1 basal cells reported previously (4, 5).Over-
all, Nkx3.1(11)-d2EGFP recapitulates the endogenous Nkx3.1
expression pattern in adult prostate homeostasis.
Androgen activates Nkx3.1 transcription through cell-
autonomous AR in both luminal cells and CARNs
To test whether androgen regulates Nkx3.1 expression
through the 11-kb region,we castratedNkx3.1(11)-d2EGFPmice
at 8 weeks of age and performed three rounds of androgen-medi-
ated serial prostate regression–regeneration (Fig. 2A). We found
that the GFP signal was dramatically decreased in the regressed
prostate (Fig. 2,BandC), consistentwith lossofNkx3.1 expression
in most luminal cells upon androgen deprivation. Importantly,
cells that retained GFP expression were strictly luminal and
expressed Nkx3.1 (Fig. 2C), and they comprised 1.4% (n 29
of 2053) of all luminal cells (Fig. 2K), suggesting that they
correspond to the previously identified CARNs (5). Upon
androgen readministration, the GFP signal was again
detected in most luminal cells (95.6%, n  1883 of 1970) of
the regenerated prostate, and the same results were observed
for both one-round and three-round regeneration experi-
ments (Fig. 2, D, E, and K). These data demonstrate that
the Nkx3.1 11-kb region is fully responsive to androgen
regulation.
Androgen-regulated luminal Nkx3.1 expression could be
mediated cell-autonomously through luminal AR and/or
through paracrine signals induced by stromal AR. To distin-
guish these two possibilities, we analyzed prostate in the midst
of regression. We found that, 2 weeks after castration of
Nkx3.1(11)-d2EGFP mice (Fig. 2A), the shrinking prostate
showed a mosaic GFP expression pattern, with the GFP
regions overlapping with luminal nuclear AR signals (Fig. 2F).
To further confirm the cell-autonomous role of androgen, we
deletedAR specifically in luminal cells using theCK18-CreERT2
driver (25) by tamoxifen induction of 8-week-old CK18-
CreERT2; ARflox/Y mice. Two weeks after induction, AR-null
luminal cells could be identified as clusters with condensed
nuclei and enhanced membrane CK18 expression, as we
reported previously (26), and we found that Nkx3.1 expression
was diminished in those cells (Fig. 2G). Direct staining of AR
andNkx3.1 in adjacent sections also confirmed this result (sup-
plemental Fig. S3A). Importantly, we found that the GFP signal
was significantly reduced inAR-null luminal cells of tamoxifen-
induced CK18-CreERT2; ARflox/Y; Nkx3.1(11)-d2EGFP mice
(Fig. 2H and supplemental Fig. S3B), indicating that luminal
cell-autonomous AR directly activates Nkx3.1 transcription
through the 11-kb region. To determine whether such a mech-
anism also applies to CARNs, we ablated AR specifically in
CARNs using the Nkx3.1CreERT2/ driver (5) in the fully
regressed prostate and analyzed GFP reporter activity. In
Nkx3.1CreERT2/; ARflox/Y; Nkx3.1(11)-d2EGFP mice that first
underwent castration and then tamoxifen induction (Fig. 2I),
the percentage of GFP luminal cells in the regressed pros-
tate was dramatically reduced by almost 10-fold to 0.16%
(n  4 of 2450) (Fig. 2, J and K), and no Nkx3.1 cells were
found by immunofluorescence staining. Therefore, Nkx3.1
Nkx3.1 in prostate stem cells and cancer
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expression in both luminal cells and CARNs are transcrip-
tionally regulated by cell-autonomous AR through the 11-kb
region.
AR preferentially binds to the Nkx3.1 3 gene locus in vivo and
in vitro
To confirm that AR interacts with the Nkx3.1 3 gene locus,
we next performed quantitative ChIP (qChIP) analyses across a
17-kbNkx3.1 region that encompasses both 7-kb upstream and
10-kb downstream sequences to its TSS (Fig. 3A). We chose to
analyze this region because it was shown previously to be capa-
ble of driving prostatic Nkx3.1 expression (4). Consistent with
our reporter mouse data, we found that AR had low affinity for
the region 5 to theNkx3.1 TSS but, instead, occupied multiple
loci in the 3 11-kb region (Fig. 3A). In particular, our statistical
analysis (see “Experimental procedures”) highlighted two bind-
Figure 1. Nkx3.1(11)-d2EGFP recapitulates Nkx3. 1 expression in adult prostate. A, the DNA construct used for generatingNkx3.1(11)-d2EGFP transgenic
mice, showing the relative position of its sequences in the mouse Nkx3.1 gene locus. Conservation of DNA in multiple placental mammal species is shown as
in the UCSC genome browser. B, white-field and GFP overlay images of dissected urogenital tissues, showing strong prostate-specific GFP expression in the
Ntg18 line.C, immunofluorescence (IF) images showingnoGFP reporter expression in E18.5prostatebud.D, IF showingGFPexpression in all prostate epithelial
cells at P8. E, IF showingGFPexpressionprimarily in luminal cells at 8weeks (8w). F, IF showing co-localizationof reporterGFP andNkx3.1 signals in luminal cells
at 5 months. G, quantitation of the percentages of GFP cells in luminal cells of different lobes and in basal cells. H, direct visualization of the GFP signal,
showing thatmostbasal cellswereGFP-negative (arrows),whereas a small proportionwasGFP (arrowheads) in adult prostate. SV, seminal vesicle. Scale bars
1 mm (B) and 20 m (C–F and H). Error bars correspond to 1 S.D.
Nkx3.1 in prostate stem cells and cancer
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ing sites with the highest affinity in the 3 UTR (“Peak3kb”)
and the intron (“Peak1kb”), respectively (Fig. 3A). To test
whether these two peaks could serve as transcriptional enhanc-
ers, we performed a luciferase reporter assay by transfection of
synthetic constructs containing anE4TATAminimal promoter
in combination with the peak regions into prostate LnCaP cells
(Fig. 3B), which express AR and are androgen-responsive (27).
Upon dihydrotestosterone (DHT) treatment, luciferase activity
for the construct containing the290-bp Peak3kb sequence
was significantly enhanced,whereas nodifferencewas observed
for the construct containing the Peak1kb sequence (Fig. 3C).
To test any potential spatial effect of the binding site arrange-
ment, we also generated constructs in which the Peak1kb and
Peak3kb sequences were positioned downstream of the lucif-
erase sequence and obtained similar results (supplemental Fig.
S4). We next used the FIMO software (28) to search for poten-
tial AR-responsive elements (AREs) within the Peak3kb
fragment based on the AR DNA-binding consensus motif
obtained from TRANSFAC (29). Three new candidate AREs
were identified, with ARE1 being a composite site containing
two 6-bp half-sites with one overlapping nucleotide and
ARE2 and ARE3 both being optimal palindromic sequences
15 bp in length (Fig. 3D). In a series of luciferase assays using
synthetic reporters containing six copies of the individual
predicted AREs (Fig. 3B), we found that both ARE2 and
ARE3, but not ARE1, significantly enhanced luciferase activ-
ities upon DHT treatment (Fig. 3E). Cumulatively, these
molecular analyses support that AR directly binds to the
11-kb region, particularly the Nkx3.1 3 UTR, to activate
Nkx3.1 transcription.
Figure 2. AR-dependent Nkx3. 1 expression in luminal cells and CARNs revealed byNkx3.1(11)-d2EGFP during prostate regression–regeneration. A,
timeline of the serial prostate regression–regenerationexperiment forNkx3.1(11)-d2EGFPmice.B, direct visualization showing relatively fewGFP cells (arrow) in the
regressedprostate.C, IF images showingthat the rareGFPcells in the regressedprostatewere luminal (CK5, left) andNkx3.1 (right).D, directvisualizationshowing
that most luminal cells recovered GFP expression after one-round prostate regeneration. E, IF image showing that most luminal cells were GFP after three-round
regression–regeneration. F, IF image showing co-localization of GFP and nuclear AR in prostate that is undergoing regression. G, IF image showing loss of Nkx3.1
expression inAR-null luminal cells (revealed by enhanced CK18 expression, arrows).H, the GFP reporter signal was strongly reduced inAR-null luminal cells in the AP
of tamoxifen-induced CK18-CreERT2; ARflox/Y; Nkx3.1(11)-d2EGFP mice. I, timeline of the experiment for AR ablation in CARNs in Nkx3.1CreERT2/; ARflox/Y; Nkx3.1(11)-
d2EGFPmice. J, almostnoGFPsignalwasobservedbydirect visualizationof theprostate in I.K, quantitationof theproportionsofGFP cells among total luminal cells
for the experiments in B,D, E, and J. **, p 0.01 by Student’s t test. Scale bars 20m. Error bars correspond to 1 S.D.
Nkx3.1 in prostate stem cells and cancer
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Pten promotes Nkx3.1 expression in vivo through
transcriptional regulation of the 11-kb region
Finally, we sought to address the question how loss of the
tumor suppressor Pten leads to down-regulation of Nkx3.1
expression in prostate tumors (19–21). We generated lineage-
marked Pten-null prostate cell clones that were identifiable as
YFP or phospho-Akt by tamoxifen-induction of CK18-Cre-
ERT2; Ptenflox/flox; R26R-YFP/ mice and confirmed that
Nkx3.1 immunostaining was abolished in those cells (Fig. 4A).
Notably, this phenomenon is not due to AR loss because strong
nuclear AR staining was still present in the Pten-null cells (Fig.
4B). Many potential causes could result in this phenotype,
including decrease ofNkx3.1 transcription,Nkx3.1mRNAdeg-
radation/modification, and Nkx3.1 protein degradation. To
determine whether Pten regulation of Nkx3.1 expression
occurs at the transcriptional level, we analyzed GFP reporter
Figure 3. AR binds to theNkx3. 111-kb3 region to enhance its gene expression.A, distribution of AR detected by qChIP analysis over the 17-kbmouseNkx3.1
locus inprostatechromatin. The relativeenrichmentsareshownas thepercentageof theDNAinput. Locationsofprimerpairs forqChIPampliconsaremarkedbyblue
triangles. ConservationsofDNA invertebrate species and inhumanare shownas in theUCSCgenomebrowser. SpecificARenrichments above thebackgroundnoise
(0.242, dashed gray line, see “Experimental procedures” for a description) were concentrated in the 11-kb region 3 next to the TSS, with the highest two peaks at
locations3kb and1kb, respectively (arrows). B, constructs for transient transfection and luciferase reporter assays. C, luciferase reporter assay comparing the
construct with the minimal promoter with those containing Peak1kb and Peak3kb sequences, showing that the Peak3kb region is androgen-responsive. D,
sequences of three candidateAREs in thePeak3kb region. E, luciferase assay comparing constructs containing six copies of eachpredictedARE, showing thatARE2
andARE3 are androgen-responsive. Error bars correspond to 1 S.D. *, p 0.05 by Student’s t test.
Nkx3.1 in prostate stem cells and cancer
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expression in tamoxifen-induced CK18-CreERT2; Ptenflox/flox;
Nkx3.1(11)-d2EGFP mice. Pten-null clones were identified by
positivity of phospho-Akt staining 2 weeks after induction (Fig.
4, C and D). Strikingly, the GFP signal was abolished in those
cells but not in neighboring wild-type cells (Fig. 4, C and D).
Triple staining of AR, phospho-Akt, and GFP also confirmed
the above findings (supplemental Fig. S5). To determine
whether the nuclear AR is functional in Pten-null cells, we iso-
lated wild-type and Pten-null luminal cells by flow-sorting of
YFP cells from tamoxifen-induced CK18-CreERT2; R26R-
YFP/ and CK18-CreERT2; Ptenflox/flox; R26R-YFP/ mice,
respectively, and performed qRT-PCR for several well-estab-
Nkx3.1 in prostate stem cells and cancer
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lished prostate AR target genes: Crabp1, Fkbp5, Mme, Msmb,
Pbsn, and Pgap2 (23, 30). Consistent with previous reports (23),
we found that expression of Pbsn,Msmb, andMme was signif-
icantly reduced inPten-null cells (Fig. 4E). However, expression
of Fkbp5, Crabp1, and Pgap2 was unchanged or modestly up-
regulated (Fig. 4E), indicating that AR is transcriptionally active
in these cells and that additional transcriptional repressors are
involved in suppressing a subset of AR target genes, including
Nkx3.1.
Discussion
In this study, we show that the 11-kb region 3 to theNkx3.1
TSS is responsible for Nkx3.1 expression alterations in adult
prostate under various physiological conditions (Fig. 4F). The
11-kb transgene was able to recapitulate the normal Nkx3.1
expression pattern in adult prostate and induce the same levels
of expression as the previously characterized 32-kb and 17-kb
transgenes (4), suggesting that the 5 sequence of the Nkx3.1
locus is dispensable for this purpose. Notably, all three frag-
ments induced Nkx3.1 expression in most but not all luminal
cells of the DLP and VP, suggesting that a distant cis-regulatory
elements exist beyond the 32-kb region to strengthen Nkx3.1
expression in those lobes. In contrast, the 11-kb fragment
induced much stronger expression in all lobes than the previ-
ously identified 5-kb urogenital enhancer at its distal 3 location
(4), suggesting that the 3 region adjacent to the Nkx3.1 TSS is
also important. Indeed, our qChIP experiments identified mul-
tiple AR binding sites in vivo in the 11-kb region but not in the
5 region. In particular, the Peak3kb sequence in the 3 UTR
was discovered as a new important androgen response region.
Using prostate cancer LnCaP cells, previous studies have iden-
tified potential AREs in various locations of the Nkx3.1 locus,
including the intron (31), the 3UTR (32, 33), and a site 5 to the
Nkx3.1 TSS (34). However, whether those sites are functional
in vivo are unknown. Using reporter mice, our prostate
regression–regeneration experiments and AR conditional
knock-out experiments showed that androgen regulation of
Nkx3.1 expression in the adult prostate is primarily mediated
by cell-autonomousAR through the 11-kb region.Wenote that
the reporter GFP signal was not completely abolished in some
AR-null luminal cell clones, indicating that other transcription
factors can also bind to the 11-kb region to enhance Nkx3.1
expression in the absence of AR (Fig. 4F).
An interesting finding from our study is that the reporter
mice labeled rare GFP luminal cells in the regressed prostate.
The frequency of those cells and their positivity for Nkx3.1
suggest that they are the previously identified luminal stem cell
CARNs. CARNs are AR (5), and we recently showed that they
require AR for proper daughter cell differentiation (26). How-
ever, how CARNs are specified remains unclear. Is their exclu-
sive Nkx3.1 expression in the regressed prostate a result of AR
expression or some other intrinsic properties that are different
from the rest of the luminal cells? Our conditional knock-out
and reporter mouse experiments indicate that Nkx3.1 expres-
sion in CARNs is also mediated by cell-autonomous AR
through the 11-kb region. We hypothesize that, after castra-
tion, residual levels of androgen secreted from the adrenal
gland may induce AR nuclear translocation in a few localized
niches, thereby specifying CARNs in the regressed prostate and
sensitizing them to AR levels. Such a model would argue that
CARNs are facultative stem cells dependent on microenvi-
ronmental cues (local androgen) rather than a pre-existing
fixed population. This model can also explain the previously
reported phenomena that CARNs tend to be clustered and
that some initially YFP lineage-marked CARNs lost Nkx3.1
expression over time (5). Our Nkx3.1(11)-d2EGFP mice
should provide a useful and convenient tool for isolation of
bona fide CARNs from the regressed prostate at any partic-
ular time and studying their molecular and functional prop-
erties. Notably, CARNs are not the only source for prostate
luminal cell regeneration because many regressed luminal
cells contribute to this process (22, 35), and Bmi1 cells were
recently shown to be a distinct type of luminal progenitor
cells competent for regeneration (36). Future work should
shed light on how this new type of progenitor cell is specified
and its relationship with CARNs.
Nkx3.1 down-regulation has been reported in a variety of
mouse prostate cancer models (20, 21, 37, 38) and is well doc-
umented in human prostate cancer initiation (10). In human
prostate cancer samples, decreases in Nkx3.1 and Pten expres-
sion levels were reported to be significantly correlated (21, 39).
Our data showing that loss of Pten abolished the GFP reporter
signal provide definitive evidence that Pten promotes Nkx3.1
expression at the transcriptional level. The presence of nuclear
AR in Pten-null clones as well as the down-regulation of a sub-
set but not all of the AR target genes indicate that AR protein is
still functional but that unknown transcriptional repressors
activated by the PI3K pathway are involved and exert their neg-
ative effects through the 11-kb region (Fig. 4F). It was proposed
that Egr1, c-Jun, and Ezh2 are up-regulated upon Pten deletion
and interact withAR to suppress its transcriptional output (23).
Further analyses of the 11-kb sequence and molecular analyses
of Pten-null luminal cells should provide potential candidates
to test. It will also be interesting to determine whether similar
Figure 4. Transcriptional regulation of Nkx3. 1 by Pten and the overall model. A, IF images showing loss of Nkx3.1 expression in Pten-null luminal cells
markedby either YFPpositivity (left panel) or phospho-Akt expression (right panel) of tamoxifen-inducedCK18-CreERT2; Ptenflox/flox; R26R-YFP/mice. Phospho-
Akt staining (red) can be distinguished from Nkx3.1 or AR staining (red) by its membrane localization. B, IF images showing nuclear AR expression in Pten-null
luminal cells. C and D, adjacent sections of phospho-Akt staining and GFP direct visualization in AP (C) and DLP (D) of tamoxifen-induced CK18-CreERT2;
Ptenflox/flox; Nkx3.1(11)-d2EGFP mice, showing that the GFP signal is abolished in Pten-null cells. Scale bars  20 m. E, qRT-PCR analyses comparing the
expression levels of selectedAR targetgenes inwild-typeandPten-null luminal cells byWelch t test. *,p0.01. Error bars correspond to1S.D. F,model ofNkx3.1
transcriptional regulation in adult prostate epithelial cells. Androgen cell-autonomously maintains Nkx3.1 expression in adult prostate epithelial cells. Upon
DHT binding, AR proteins in the cytoplasm dimerize and translocate into the nucleus. They preferentially bind to the 11-kb Nkx3.1 3 region to the TSS,
particularly the 3 UTR, to activate Nkx3.1 transcription. Other transcription activators also bind to this region (shaded red triangle) and play a minor role in
activatingNkx3.1 transcription (dashedarrow). Transcriptional repressors that arenormally inhibitedbyPtencanalsobind to this region (shadedyellow triangle)
and strongly inhibit Nkx3.1 transcription, even in the presence of nuclear AR.
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transcriptional regulatory mechanisms exist for Nkx3.1 down-
regulation under other tumor-initiating conditions.
Experimental procedures
Generation of Nkx3.1(11)-d2EGFPmice
The Nkx3.1(11)-d2EGFP construct is comprised of the
10.5-kb mouse genomic sequence (UCSC genome browser,
mm9 Chr 14: 69808515-69819104) at the Nkx3.1 locus (234/
10356) containing a 240-bp proximal promoter, exon 1,
intron, exon 2, and 6.5-kb 3 region as well as the d2EGFP
(Clontech) and SV40 poly(A) sequences inserted right after the
Nkx3.1 start codon. The construct (11671-bp total length) was
synthesized byGenScript and cloned into a pUC57 vector.MluI
andXhoI restriction enzyme sites were engineered at both ends
of the synthesized sequence for plasmid linearization. The
transgenic mouse lines were generated by pronuclear injection
of fertilized eggs by Cyagen Biosciences.
Mouse genotyping and operations
The CK18-CreERT2 transgenic line (25), Nkx3.1CreERT2/
targeted allele (5), ARflox allele (40), Ptenflox allele (41), and
R26R-YFP line (42) were described previously. Animals were
maintained in C57BL/6N background. Genotyping was per-
formed by PCR using tail genomic DNA; primer sequences are
listed in supplemental Table S2. The Nkx3.1(11)-d2EGFP
transgene was genotyped by a set of primers amplifying the
junction between the proximal promoter and the d2EGFP
sequence. The following primers generated a 319-bpPCRprod-
uct: 5-AAGGGCTCTGGAGCCTAATC-3 (forward) and 5-
GAACTTCAGGGTCAGCTTGC-3 (reverse).
For tamoxifen induction, mice were administered 9 mg/40 g
of body weight tamoxifen (Sigma) suspended in corn oil by oral
gavage once daily for 4 consecutive days. Castration of adult
male mice was performed using standard techniques. For pros-
tate regeneration, testosterone (Sigma) was dissolved at 25
mg/ml in 100% ethanol and diluted in PEG-400 to a final con-
centration of 7.5 mg/ml. Testosterone was administered for 4
weeks at a rate of 1.875 g/h, delivered by subcutaneous
implantation of mini-osmotic pumps (Alzet). All animal exper-
iments received approval from the Institutional Animal Care
and Use Committee at UCSC.
GFP visualization, immunofluorescence staining, and cell
quantitation
Prostate tissue dissection and direct GFP visualization were
performed under a Nikon SMZ-1000 stereomicroscope with
fluorescence and charge-coupled device digital camera. Tissues
were fixed in 4% paraformaldehyde for subsequent cryo-em-
bedding in OCT compound (Sakura). Immunofluorescence
staining was performed as described previously (26). Slides
were mounted with VectaShield mounting medium with DAPI
(Vector Laboratories). Images were obtained using a Leica TCS
SP5 spectral confocal microscope in the Microscopy Shared
Facility of UCSC. All primary antibodies and dilutions used are
listed in supplemental Table S3. Nkx3.1, AR, and pAkt primary
antibodies were all raised in rabbits, but their expression can be
distinguished in co-staining because pAkt signal is on themem-
brane, whereas AR and Nkx3.1 signals are nuclear. For AR and
Nkx3.1 co-staining, adjacent cryosections of 3-m thickness
were used.
Cell numbers were counted manually using confocal40 and
63photomicrographsacross tissue sections.Threeanimalswere
counted for each group. Basal cellswere identified basedon lackof
CK18 staining, positivity for CK5 staining, and/or the shape of the
cells (oval or triangular) and their positions at the basement of the
epithelium. Luminal cells were determined based on positive
CK18 staining and/or the shape of the cells (columnar) and their
positions at the apical side of the epithelium.
Flow cytometry
To sort luminal cells, lineage-marked prostate tissues were
dissected andminced into small clumps, followed by enzymatic
dissociation with 0.2% collagenase I (Invitrogen) in DMEM
with 5% FBS for 3 h at 37 °C. Tissues were digested with 0.25%
trypsin-EDTA (StemCell Technologies) for 1 h at 4 °C, passed
through 21- to 26-gauge syringes, and filtered through a 40-m
cell strainer to obtain single-cell suspensions. Dissociated pros-
tate cells were suspended inHanks’ balanced salt solutionmod-
ified/2% FBS. The Rho-associated protein kinase (ROCK)
inhibitor Y-27632 (StemCell Technologies) was added at 10M
throughout the whole process to inhibit luminal cell death, and
dead cells were excluded by propidium iodide staining. Luminal
cells were sorted based on YFP positivity on a BD FACS Aria II
instrument in the flow cytometry shared facility of UCSC.
Quantitative real-time PCR analysis
Total RNA from FACS-purified luminal cells was isolated
using the RNeasy micro kit (Qiagen) and reverse-transcribed
into cDNA using SuperScript IV VILO Master Mix (Invitro-
gen). Quantitative real-time PCR was carried out using Power
SYBR Green PCR Master Mix (Life Technology) in the ViiA 7
real-time PCR instrument. cDNA samples were diluted 1:100 for
all analyses, which were performed in quadruplicate. Expression
values were obtained using the 		CTmethod and normalized to
-actin expression; average values are shown as the mean
 S.D.
Welch two-sample t testwasperformed.Theprimersequences for
qRT-PCR are provided in supplemental Table S4.
Quantitative ChIP and statistics
The Magna ChIPTM HiSens chromatin immunoprecipita-
tion kit (Millipore) was used according to the instructions of
the manufacturer. Formaldehyde cross-linked chromatin was
obtained from adult mouse prostate and sheared by sonication
(average size, 600 bp). Aliquots of chromatin from2mgof pros-
tate tissue were incubated with 2 g of anti-AR antibody
(Sigma, catalog no. A9853) bound to 40 l of protein A/G-
coated magnetic beads from the kit. The immunoprecipitates
were washed three times by SCWbuffer of the kit with protease
inhibitormixture and resuspended inChIP elution buffer. After
1 h of incubation at 55 °C, the cross-links were reversed by 3-h
incubation at 65 °C. Genomic DNA was resuspended into 150
l of water.
The amounts of each specific DNA fragment in immunopre-
cipitates were determined by quantitative PCR reactions using
a standard curve generated for each primer set with 0.04%,
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0.2%, and 1% input DNA samples. The primer sequences are
provided in supplemental Table S5. The PCR products were
between 80 and 120 bp. Reactions were carried out using the
ViiATM 7 real-time PCR system and 2 SYBR mixture (ABI).
Cycle threshold values were transformed into DNA copy num-
bers using a standard curve. The copy number of each specific
DNA fragment was compared with the value before immuno-
precipitation (input DNA). The control antibody (rabbit nor-
mal IgG, Millipore, catalog no. CS200581) was included for
each set of the quantitative PCR experiments. The enrichment
obtained with IgG was subtracted from the corresponding
value obtained with anti-AR antibody. To determine a thresh-
old value that distinguishes real binding signals from back-
ground noise, statistical analysis was conducted using R Soft-
ware (version 2.13.1). Analysis of variance was performed for
theAR signals obtained from all 16 qChIP amplicon sites (seven
amplicons 5 to and nine amplicons 3 to the TSS), and Fisher’s
least significant difference test was performed to separate the
16 sites into the following six groups with a descending order in
the signal intensity:3 kb (3UTR)1 kb (intron),2 kb (3
UTR)5 kb,4 kb6 kb,10 kb0.2 kb the other
eight sites (background noise). Student’s t test for the last group
showed the 99% confidence interval of the background signal
value to be 0.107–0.242, indicating that all regions having sig-
nals higher than 0.242 should be considered specific AR-bind-
ing regions.
Plasmid construction, transfection, and luciferase reporter
assays
The sequences of the Peak1kb and Peak3kb regions and
six copies of the predicted AREs with a minimal E4TATA pro-
moter were synthesized by GenScript and then subcloned into
the firefly luciferase reporter vector in the pGL3-Basic plasmid
(Promega). Transient transfections were conducted by Lipo-
fectamine 2000 (Invitrogen) in LnCaP cells (ATCC,CRL-1740).
The cells were cultured in RPMI 1640mediumwith 10% FBS in
24-well plates for 36 h before transfection to ensure complete
cell attachment and growth to70% confluence. For transfec-
tion, 1.6 g of firefly luciferase reporter plasmid and 40 ng of
Renilla-TK (Promega) internal control plasmid were mixed
with 2.5 l of Lipofectamine 2000 in 100 l of Opti-MEM (Life
Technologies). The mixture was then incubated with the cells
for 5 h before being replaced with cell culture medium with or
without 106 M DHT. The Dual-Luciferase reporter assays
(Promega) were performed after 48 h of DHT stimulation
according to the instructions of the manufacturer and were
repeated twice in triplicates. Statistical evaluation of luciferase
activities was performed using two-sided Student’s t test.
Prediction of AREs in the Peak3kb region
To search for candidate AREs in the Peak3kb region, Find
Individual Motif Occurrence (FIMO), a motif-based sequence
analysis software of MEME Suite 4.11.3 (http://meme-suite.
org/index.html)4 (43) was runwith a 15-bpAR consensusmotif
(V$AR_01 - AR) from TRANSFAC, a manually curated data-
base of eukaryotic transcription factor binding sites. The 15-bp
optimal AR bindingmotif is a palindromic sequence containing
two 6-bp AR binding half-sites separated by 3-bp random
nucleotides with a head-to-head arrangement. Prediction was
also performed by FIMO using the AR binding half-site
sequence. Filter criteria with the match p  104 was used to
identify the three potential AREs.
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Supplementary Figures and Tables 
 
Figure S1. Characterization of other Nkx3.1(11)-d2EGFP mouse lines. 
White field and GFP channel overlay images of dissected urogenital tissues showing 
various degrees of GFP expression in prostate lobes for the other four weaker 
Nkx3.1(11)-d2EGFP transgenic lines. The green signal in bladders was due to 
autofluorescence of urine. 
	 2	
 
 
 
Figure S2. Characterization of Nkx3.1(11)-d2EGFP in neonatal prostate and 
different adult prostate lobes. 
(A) IF image showing GFP reporter and Nkx3.1 co-localization in the prostate epithelium 
of mice at stage P8. (B-D) Representative IF images showing GFP reporter expression 
present in luminal cells of adult prostate at 8 weeks of age, with the following order of 
penetration in different lobes: AP>DLP>VP. Scale bars correspond to 20 microns.  
 
 
 
 
 
	 3	
 
 
Figure S3. AR activates Nkx3.1 transcription through the 11-kb in luminal cells. 
(A) IF staining of adjacent sections of tamoxifen-induced CK18-CreERT2; ARflox/Y mice 
showing the absence of Nkx3.1 signal in AR-deleted prostate luminal cells (arrow). (B) 
GFP reporter signal was strongly reduced in AR-null luminal cells in the DLP of 
tamoxifen-induced CK18-CreERT2; ARflox/Y; Nkx3.1(11)-d2EGFP mice. Scale bars 
correspond to 20 microns. 
										
	 4	
			
				
Figure S4. Luciferase assays to test candidate enhancers. 
(A) Constructs for transient transfection and luciferase assays with the candidate 
enhancers positioned downstream of the luciferase sequence. (B) Luciferase reporter 
assays comparing the construct with only the minimal promoter to those containing 
“Peak+1kb” and “Peak+3kb” sequences downstream of the luciferase sequence showing 
that the “Peak+3kb” region is androgen responsive. Error bars correspond to one s.d. * p 
< 0.05 by student’s t test. 
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Figure S5. Absence of GFP reporter signal in Pten-null luminal cells. 
Triple IF staining showing that Pten-null luminal cells, which were identified by pAkt 
signal (membrane red), still expressed nuclear AR (nuclear red), but lost the GFP reporter 
expression. Scale bar corresponds to 20 microns. 
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Table S1. Summary of GFP expression intensity in five Nkx3.1(11)-d2EGFP 
transgenic lines. 
 
 
Transgenic 
mouse lines 
GFP expression 
in embryos 
GFP expression in adult prostate 
AP VP DLP 
Ntg16 negative strong weak weak 
Ntg18 negative strong strong strong 
Ntg27 negative moderate weak weak 
Ntg28 negative weak weak weak 
Ntg41 negative strong moderate strong 
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Table S2. Primers for mouse genotyping. 
 
 
Allele  Primer sequence 
CreERT2 
forward 5’-CAGATGGCGCGGCAACACC-3’ 
reverse 5’-GCGCGGTCTGGCAGTAAAAAC-3’ 
ARflox 
forward 5’-GTTGATACCTTAACCTCTGC-3’ 
reverse 5’-CTTCAGCGGCTCTTTTGAAG-3’ 
Ptenflox 
forward 5’-ACTCAAGGCAGGGATGAGC-3’ 
reverse 5’-GTCATCTTCACTTAGCCATTGG-3’ 
R26R-YFP 
wild-type forward 5’-GGAGCGGGAGAAATGGATATG-3’ 
mutated forward 5’-GCGAAGAGTTTGTCCTCAACC-3’ 
reverse 5’-AAAGTCGCTCTGAGTTGTTAT-3’ 
Nkx3.1 
wild-type forward 5’-CTCCGCTACCCTAAGCATCC-3’ 
wild-type reverse 5’-GACACTGTCATATTACTTGGACC-3’ 
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Table S3. Antibodies used for immunofluorescence. 
 
 
Antigen Supplier Ig type Dilution 
AR Sigma #A9853 rabbit IgG 1:400 
CK5 Covance #PRB-160P rabbit IgG 1:500 
CK18 Abcam #ab668 mouse IgG1 1:100 
Nkx3.1 Kim et al. (2002) PNAS 99: 2884-2889 rabbit IgG 1:2000 
Phospho-Akt Cell Signaling #3787 rabbit IgG 1:50 
GFP Abcam #13970 chick IgY 1:2000 
YFP Abcam #13970 chick IgY 1:2000 
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Table S4. List of primer sequences for qRT-PCR 
 
 
Genes Forward (5' to 3') Reverse (5' to 3') 
Fkbp5 GGGATGTTGTCAGATGGAAAG TGTCCCAGGCTTTGATAACC 
Crabp1 CGCTACAGCCAACACCACT TCAGCATGGCGTTCACAC 
Pgap2 TCCACTTGTCGCCTTCTTCT CACTGATGGCAGGTAATTGG 
Msmb TGGTGATAGCATCCAAAGCA AGCATCCATGCAGTCATCAG 
Pbsn ACACGAGTGGCTGGAGTTTT TCCTCAATGCCCATTTCTTC 
Mme CGAGACCAGTTCCCGATACA TTTTTGCTTTCTGCACTGCT 
Actb CCAACCGTGAAAAGATGACC CCATCACAATGCCTGTGGTA 
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Table S5. List of primer sequences for qChIP 
 
 
Location Forward (5' to 3') Reverse (5' to 3') 
-6.5 kb ACTGGTGGCCAAAGTTCTGA TGGAAGTAGGGAAACTGAGGTC 
-5.5 kb GCCACCCAGTCAGAGGATAG ATACAATAGTGCCCCGGTGA 
-4.5 kb CCAAAGAGCAAAGGGACAAG GTCAGGCCCTTGACTTTCAC 
-3.5 kb GCAGTGCGAACACTCTTGAC GAAGGAGGGGAGGCTAACAG 
-2.5 kb ATGGCCAGGGCTAATAAGGT AGCCGCTCTTCTGTGTGACT 
-1.3 kb AGTTTCCCTCCGAAGTTGCT GCTCTGCAGGGAACCTTGT 
-0.2 kb GAGAGGGAAACCAGGAAAGG GCTCCAGGTGACCCTCAAG 
+1 kb ACACACATCCAGGATCCACA ACATTCAGGTCTTAGCGGTTT 
+2 kb ATGGCCCCTTAGATGAGGAT AAGGGCAGAGAGAAACTCTGG 
+3 kb GGGGTGCTTGTTTTTCATGT CTCCTTGCTGGTTAGCTTGG 
+4 kb TGCGTGTGGTTTTCAGATTC AGTGTCCTGTGGGAACATGG 
+5 kb GTGCCTACTTCAGGCAATCC CATGCTTCTTGCCTGCTACA 
+6 kb TGTGCAAGAGAAAGGGCATA AAGTCTGCAGAGGAGCCAAA 
+7 kb CCAAGAGAGTGGGTTTTCCA TCATTGCATGGCAAGAACAT 
+8 kb TATGCCCTGCAGCCATAAG TAGCTTTGGGCTAGGGTTCC 
+9.5 kb TCTGAGGGAAGGTGTCCTTG CCACCCTACTTCTCTGGGATG 		
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